Express News | Deep Track Biotechnology Master Fund, Ltd. Reports 9.56% Stake in Dynavax Technologies Corp as of Sept 16- SEC Filing
Federated Hermes, Inc. Reduces Stake in Dynavax Technologies Corp
50 Stocks That May See Selling Pressure as Investors Begin Looking to Book Tax Losses
Express News | Lantheus Holdings : Board Will Be Comprised of Ten Directors
Lantheus Appoints Julie Eastland as New Board Member
Shingles Therapeutics Pipeline Market Insights Report 2024 Featuring Zhuhai Trinomab, Nobelpharma, Dynavax Technologies, Jiangsu Rec-Biotechnology, Moderna, Curevo, and Amytrx Therapeutics
Dynavax Technologies Corporation Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next
Assessing Dynavax Technologies: Insights From 4 Financial Analysts
Express News | Goldman Sachs Maintains Neutral on Dynavax Technologies, Lowers Price Target to $15
Several Dynavax Technologies Insiders Sell Shares Sending Potential Negative Signal
HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Dynavax Technologies Analyst Ratings
Earnings Call Summary | Dynavax Technologies(DVAX.US) Q2 2024 Earnings Conference
Dynavax's Market Dominance and Buoyant Growth Prospects Affirm Buy Rating
Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript
Dynavax Technologies Corporation (DVAX) Q2 2024 Earnings Call Transcript
Dynavax's Strong Growth and Market Share Expansion Drive Buy Rating
Express News | Dynavax Reaffirms 2024 HEPLISAV-B Net Product Revenue Guidance Of $265M-$280M
Express News | Dynavax Technologies Corp: Reiterating Its Full Year 2024 Financial Guidance
Dynavax Technologies | 10-Q: Q2 2024 Earnings Report